Annual report pursuant to Section 13 and 15(d)

Statement of Cash Flows

Statement of Cash Flows
12 Months Ended
Nov. 30, 2016
USD ($)
Cash Flows from Operating Activities  
Net loss $ (90,189)
Changes in operating assets and liabilities  
Increase in prepaid expenses (32,219)
Increase in accounts payable 24,750
Increase in accrued liabilities 25,500
Net cash used in operating activities (72,158)
Net cash used in Investing Activities,  
Cash deposited in Trust Account (70,386,222)
Interest income earned on Trust Account (56,393)
Net cash used in investing activities (70,442,615)
Cash Flows from Financing Activities  
Proceeds from sale of Sponsors' shares of common stock 25,000
Proceeds from sale of Public Offering Units, including partial exercise of over-allotment option, net of offering expenses paid 66,995,417
Proceeds from sale of Private Placement Warrants 3,985,244
Payments to related parties (including loans) (250,535)
Contributions from related parties (including loans) 250,535
Net cash provided by financing activities 71,005,661
Net increase in cash 490,888
Cash at beginning of period
Cash at end of period 490,888
Supplemental Schedule of Non-Cash Financing Activities:  
Deferred underwriting fees 1,725,153
Common stock issued for additional underwriter compensation 1,061,640
Fair value of unit purchase option issued to underwriter $ 781,385